Dimensional Fund Advisors LP Nkarta, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Nkarta, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 283,176 shares of NKTX stock, worth $665,463. This represents 0.0% of its overall portfolio holdings.

Number of Shares

283,176

Previous 132,306 114.03%

Holding current value

$665,463

Previous $781,000 63.76%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$4.52 - $8.0 $681,932 - $1.21 Million	150,870 Added 114.03%	283,176 $1.28 Million
Q2 2024 Aug 09, 2024	BUY	$5.27 - $10.82 $187,838 - $385,657	35,643 Added 36.87%	132,306 $781,000
Q1 2024 May 10, 2024	BUY	$5.59 - $15.71 $224,024 - $629,593	40,076 Added 70.82%	96,663 $1.04 Million
Q4 2023 Feb 07, 2024	BUY	$1.31 - $6.6 $42,145 - $212,335	32,172 Added 131.77%	56,587 $373,000
Q3 2023 Nov 09, 2023	SELL	$1.39 - $2.29 $39,289 - $64,729	-28,266 Reduced 53.66%	24,415 $33,000
Q2 2023 Aug 09, 2023	BUY	$2.19 - $5.17 $30,489 - $71,976	13,922 Added 35.92%	52,681 $115,000
Q1 2023 May 12, 2023	SELL	$3.37 - $6.3 $100,880 - $188,590	-29,935 Reduced 43.58%	38,759 $137,000
Q4 2022 Feb 09, 2023	SELL	$5.14 - $14.35 $100,929 - $281,776	-19,636 Reduced 22.23%	68,694 $411,000
Q3 2022 Nov 10, 2022	BUY	$12.27 - $18.39 $63,227 - $94,763	5,153 Added 6.2%	88,330 $1.16 Million
Q2 2022 Aug 12, 2022	BUY	$7.77 - $19.44 $646,285 - $1.62 Million	83,177 New	83,177 $1.03 Million

Others Institutions Holding NKTX

# of Institutions

127

Shares Held

66.5M

Call Options Held

173K

Put Options Held

20K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $114M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Nkarta, Inc. Transaction History